Aurobindo Pharma Ltd. NSE: AUROPHARMA | BSE: 524804

Slowing Down Stock

Download real time

1022.20 -2.80 (-0.27%)

Near 52W Low of ₹1010.00

963.4K

NSE+BSE Volume

NSE 02 Sep, 2025 3:31 PM (IST)

USFDA Observation

Aurobindo Pharma's API facility in Telangana gets Form 483 with 3 observations from the US FDA See details

Aurobindo Pharma Ltd. News and Updates

Name: Latest research reports of Aurobindo Pharma Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Aurobindo Pharma Ltd.
Rating: 5
Author: Prabhudas Lilladhar

Keep track of all breaking news on Aurobindo Pharma Ltd. from all sources in a single place.

Is Aurobindo Pharma Ltd. worth buying?

1256 Votes:

Buy 80.25%

Sell 13.77%

Hold 5.97%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf